<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="Central and other publicly funded repositories, such as the WHO" exact="COVID" post="database with rights for unrestricted research re-use and analyses"/>
 <result pre="drugs that previously proved its efficiency against the newly emerged" exact="viral infection." post="Highlights •COVID-19 RdRp shares 97% sequence identity to SARS."/>
 <result pre="carry out the testing for the newly emerged outbreak and" exact="infection" post="prevention and control guidance [4,5]. COVID-19 viral pneumonia is"/>
 <result pre="emerged outbreak and infection prevention and control guidance [4,5]. COVID-19" exact="viral pneumonia" post="is related to the seafood market when an unknown"/>
 <result pre="outbreak and infection prevention and control guidance [4,5]. COVID-19 viral" exact="pneumonia" post="is related to the seafood market when an unknown"/>
 <result pre="symptoms include fever, malaise, dry cough, shortness of breath, and" exact="respiratory" post="distress [2]. COVID-19 is a member of Betacoronaviruses like"/>
 <result pre="distress [2]. COVID-19 is a member of Betacoronaviruses like the" exact="Severe" post="Acute Respiratory Syndrome Human coronavirus (SARS HCoV) and the"/>
 <result pre="[2]. COVID-19 is a member of Betacoronaviruses like the Severe" exact="Acute" post="Respiratory Syndrome Human coronavirus (SARS HCoV) and the Middle-East"/>
 <result pre="COVID-19 is a member of Betacoronaviruses like the Severe Acute" exact="Respiratory" post="Syndrome Human coronavirus (SARS HCoV) and the Middle-East Respiratory"/>
 <result pre="is a member of Betacoronaviruses like the Severe Acute Respiratory" exact="Syndrome" post="Human coronavirus (SARS HCoV) and the Middle-East Respiratory Syndrome"/>
 <result pre="Acute Respiratory Syndrome Human coronavirus (SARS HCoV) and the Middle-East" exact="Respiratory" post="Syndrome Human coronavirus (MERS HCoV) [10,11]. Until today, six"/>
 <result pre="Respiratory Syndrome Human coronavirus (SARS HCoV) and the Middle-East Respiratory" exact="Syndrome" post="Human coronavirus (MERS HCoV) [10,11]. Until today, six different"/>
 <result pre="including coronaviruses. RdRp is targeted in different RNA viruses, including" exact="Hepatitis" post="C Virus (HCV), Zika Virus (ZIKV), and coronaviruses (CoVs)"/>
 <result pre="Drugs Administration (FDA), such as Sofosbuvir, Ribavirin against RdRp of" exact="Hepatitis" post="C Virus (HCV). These drugs are nucleotides derivative competing"/>
 <result pre="is 109.5 μM, while its half-maximum Inhibition Concentration (IC50) against" exact="Dengue" post="virus is 8 μM [29,30]. Sofosbuvir show 4 μM"/>
 <result pre="nucleotide inhibitors due to its strong evidence of inhibiting emerging" exact="viral" post="RdRps [11,16]. We build the COVID-19 RdRp model using"/>
 <result pre="approved drug by the Food and Drugs Administration (FDA) against" exact="Hepatitis" post="C Virus (HCV) Non-structural protein 5 (NS5B) RdRp in"/>
 <result pre="used to treat Ebola virus, Marburg virus, MERS and SARS" exact="infections" post="[57]. Cinnamaldehyde and Thymoquinone are negative control compounds that"/>
 <result pre="the Betacoronaviruses (OC43, HKU1, SARS, MERS, and COVID-19). SARS HCoV" exact="secondary" post="structure is shown at the top of the MSA"/>
 <result pre="nucleotides (ATP, GTP, CTP, and UTP) [23,25]. Fig. 1 (A)" exact="Multiple" post="sequence alignment of all the HCoV strains (229E, NL63,"/>
 <result pre="indicate identical residues while yellow highlighted residues are less conserved." exact="Secondary" post="structures are represented at the top of the MSA"/>
 <result pre="Two views of the polymerase at 180o rotation on the" exact="horizontal" post="plane are shown (top and bottom). The active site"/>
 <result pre="HCoV RdRp is the closest strain to the COVID-19. The" exact="complete" post="genome for Wuhan SARS-like HCoV has a sequence identity"/>
 <result pre="and 1.6 kcal/mol, respectively. Additionally, all the tested compounds show" exact="lower" post="(better) binding energies to COVID-19 RdRp compared to SARS"/>
 <result pre="RdRp. The negative control compounds Cinnamaldehyde and Thymoquinone both show" exact="lower" post="binding affinities to either SARS or COVID-19 (higher than"/>
 <result pre="complex. (B) The overall 3D structure complexes arranged as (A)." exact="Protein" post="is represented in ribbon, and ligands are in sticks"/>
 <result pre="and hence contradict the function of the protein leading to" exact="viral" post="eradication. Additionally, IDX-184 show more promising results then comes"/>
 <result pre="outbreak in the Middle East region has an entirely different" exact="infection" post="pattern (MERS) leaving &amp;gt;800 deaths and 2500 hospitalizations. The"/>
 <result pre="possible inhibitors, DAA drugs, currently in the market stop the" exact="infection" post="immediately. Sofosbuvir, Ribavirin, and Remdisivir can be used against"/>
 <result pre="latest 2019 novel coronavirus outbreak in Wuhan, ChinaInternational Journal of" exact="Infectious" post="Diseases91202026426631953166 3Organization WHSurveillance Case Definitions for Human Infection With"/>
 <result pre="Journal of Infectious Diseases91202026426631953166 3Organization WHSurveillance Case Definitions for Human" exact="Infection" post="With Novel Coronavirus (nCoV): Interim Guidance v1, January 20202020World"/>
 <result pre="Prevention and Control during Health Care When Novel Coronavirus (nCoV)" exact="Infection" post="Is Suspected: Interim Guidance, January 20202020World Health Organization 5Organization"/>
 <result pre="Site Predictionpreprint2020 9YangL.China Confirms Human-to-Human Transmission of Coronavirus2020 10ChanJ.F.LauS.K.ToK.K.ChengV.C.WooP.C.YuenK.-Y.Middle East" exact="respiratory" post="syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like diseaseClin. Microbiol."/>
 <result pre="Predictionpreprint2020 9YangL.China Confirms Human-to-Human Transmission of Coronavirus2020 10ChanJ.F.LauS.K.ToK.K.ChengV.C.WooP.C.YuenK.-Y.Middle East respiratory" exact="syndrome" post="coronavirus: another zoonotic betacoronavirus causing SARS-like diseaseClin. Microbiol. Rev.28201546552225810418"/>
 <result pre="virus drugs against human corona virusesJ. Med. Virol.8920171040104727864902 12WHOMiddle East" exact="Respiratory" post="Syndrome Coronavirus (MERS-CoV)2016WHO 13Báez-SantosY.M.MielechA.M.DengX.BakerS.MesecarA.D.Catalytic function and substrate specificity of"/>
 <result pre="drugs against human corona virusesJ. Med. Virol.8920171040104727864902 12WHOMiddle East Respiratory" exact="Syndrome" post="Coronavirus (MERS-CoV)2016WHO 13Báez-SantosY.M.MielechA.M.DengX.BakerS.MesecarA.D.Catalytic function and substrate specificity of the"/>
 <result pre="the papain-like protease domain of nsp3 from the Middle East" exact="respiratory" post="syndrome coronavirusJ. Virol.882014125111252725142582 14HemidaM.G.AlnaeemA.Some one health based control strategies"/>
 <result pre="papain-like protease domain of nsp3 from the Middle East respiratory" exact="syndrome" post="coronavirusJ. Virol.882014125111252725142582 14HemidaM.G.AlnaeemA.Some one health based control strategies for"/>
 <result pre="14HemidaM.G.AlnaeemA.Some one health based control strategies for the Middle East" exact="respiratory" post="syndrome coronavirusOne Health.8201910010231485476 15Organization WHClinical Management of Severe Acute"/>
 <result pre="one health based control strategies for the Middle East respiratory" exact="syndrome" post="coronavirusOne Health.8201910010231485476 15Organization WHClinical Management of Severe Acute Respiratory"/>
 <result pre="Middle East respiratory syndrome coronavirusOne Health.8201910010231485476 15Organization WHClinical Management of" exact="Severe" post="Acute Respiratory Infection When Middle East Respiratory Syndrome Coronavirus"/>
 <result pre="East respiratory syndrome coronavirusOne Health.8201910010231485476 15Organization WHClinical Management of Severe" exact="Acute" post="Respiratory Infection When Middle East Respiratory Syndrome Coronavirus (MERS-CoV)"/>
 <result pre="respiratory syndrome coronavirusOne Health.8201910010231485476 15Organization WHClinical Management of Severe Acute" exact="Respiratory" post="Infection When Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection"/>
 <result pre="syndrome coronavirusOne Health.8201910010231485476 15Organization WHClinical Management of Severe Acute Respiratory" exact="Infection" post="When Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection Is"/>
 <result pre="WHClinical Management of Severe Acute Respiratory Infection When Middle East" exact="Respiratory" post="Syndrome Coronavirus (MERS-CoV) Infection Is Suspected: Interim Guidance2019World Health"/>
 <result pre="Management of Severe Acute Respiratory Infection When Middle East Respiratory" exact="Syndrome" post="Coronavirus (MERS-CoV) Infection Is Suspected: Interim Guidance2019World Health Organization"/>
 <result pre="Acute Respiratory Infection When Middle East Respiratory Syndrome Coronavirus (MERS-CoV)" exact="Infection" post="Is Suspected: Interim Guidance2019World Health Organization 16ElfikyA.A.Zika viral polymerase"/>
 <result pre="Coronavirus (MERS-CoV) Infection Is Suspected: Interim Guidance2019World Health Organization 16ElfikyA.A.Zika" exact="viral" post="polymerase inhibition using anti-HCV drugs both in market and"/>
 <result pre="inhibitorFutur. Virol.122017339347 24GanesanA.BarakatK.Applications of computer-aided approaches in the development of" exact="hepatitis" post="C antiviral agentsExpert Opin. Drug Discovery122017407425 25DoublieS.EllenbergerT.The mechanism of"/>
 <result pre="26ElfikyA.A.IsmailA.M.Molecular docking revealed the binding of nucleotide/side inhibitors to Zika" exact="viral" post="polymerase solved structuresSAR QSAR Environ. Res.29201840941829652194 27EzatA.A.ElfikyA.A.ElshemeyW.M.SalehN.A.Novel inhibitors against"/>
 <result pre="change in HCV treatmentJ Clin Transl Hepatol.32015273526357632 32BermanH.HenrickK.NakamuraH.Announcing the worldwide" exact="Protein" post="Data BankNat Struct Mol Biol.102003980– 33NCBINational Center of Biotechnology"/>
 <result pre="and subtype profiling of PSI-7977 as a nucleotide inhibitor of" exact="hepatitis" post="C virusAntimicrob. Agents Chemother.5620123359336822430955 47ElfikyA.A.GWA.EWM.MA.Hepatitis C viral polymerase inhibition"/>
 <result pre="nucleotide inhibitor of hepatitis C virusAntimicrob. Agents Chemother.5620123359336822430955 47ElfikyA.A.GWA.EWM.MA.Hepatitis C" exact="viral" post="polymerase inhibition using directly acting antivirals, a computational approachSoftware"/>
 <result pre="Res.137201713414027902933 50SacramentoC.Q.de MeloG.R.RochaN.LVBH.MesquitaM.de FreitasC.S.The clinically approved antiviral drug sofosbuvir impairs" exact="Brazilian" post="zika virus replicationSci Rep.720174092028098253 51Cretton-ScottE.PerigaudC.PeyrottesS.LickliderL.CamireM.LarssonM.588 in vitro antiviral activity"/>
 <result pre="(R7128) are better than their parent nucleotides and ribavirin in" exact="hepatitis" post="C virus inhibition: a molecular modeling studyJ. Comput. Theor."/>
 <result pre="and pharmacokinetics of IDX184, a liver-targeted nucleotide polymerase inhibitor of" exact="hepatitis" post="C virus, in healthy subjectsAntimicrob. Agents Chemother.552011768121060109 54GaneE.J.StedmanC.A.HylandR.H.DingX.SvarovskaiaE.SymondsW.T.Nucleotide polymerase"/>
 <result pre="subjectsAntimicrob. Agents Chemother.552011768121060109 54GaneE.J.StedmanC.A.HylandR.H.DingX.SvarovskaiaE.SymondsW.T.Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for" exact="hepatitis" post="CN. Engl. J. Med.3682013344423281974 55GlueP.The Clinical Pharmacology of Ribavirin."/>
 <result pre="compared with interferon alfa-2b plus ribavirin for initial treatment of" exact="chronic hepatitis" post="C: a randomised trialLancet358200195896511583749 57WarrenT.K.JordanR.LoM.K.RayA.S.MackmanR.L.SolovevaV.Therapeutic efficacy of the small"/>
 <result pre="with interferon alfa-2b plus ribavirin for initial treatment of chronic" exact="hepatitis" post="C: a randomised trialLancet358200195896511583749 57WarrenT.K.JordanR.LoM.K.RayA.S.MackmanR.L.SolovevaV.Therapeutic efficacy of the small"/>
</results>
